ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 59 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 5,068,233 | $8,058,490 | 9.56% |
| BML Capital Management, LLC | 5,157,179 | $8,199,915 | 7.38% |
| Sonic GP LLC | 2,000,000 | $3,180,000 | 2.12% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,900,000 | 1.79% |
| VR Adviser, LLC | 3,886,246 | $6,179,131 | 0.99% |
| AIGH Capital Management LLC | 1,483,557 | $2,358,856 | 0.96% |
| Acuitas Investments, LLC | 613,328 | $975,192 | 0.57% |
| Newtyn Management, LLC | 1,000,000 | $1,590,000 | 0.38% |
| Worth Venture Partners, LLC | 370,683 | $589,386 | 0.32% |
| Monaco Asset Management SAM | 235,000 | $373,650 | 0.10% |
| Quinn Opportunity Partners LLC | 398,298 | $633,294 | 0.09% |
| Soleus Capital Management, L.P. | 320,000 | $508,800 | 0.06% |
| Marquette Asset Management, LLC | 121,393 | $193,015 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 122,676 | $195 | 0.02% |
| Lipe & Dalton | 15,000 | $24 | 0.01% |
| CANTOR FITZGERALD, L. P. | 162,838 | $258,912 | 0.01% |
| XTX Topco Ltd | 16,332 | $25,968 | 0.01% |
| Renaissance Technologies | 1,216,641 | $1,934 | 0.00% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 19,432 | $30,897 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 485,340 | $771,691 | 0.00% |
External links
This page lists ADVERUM BIOTECHNOLOGIES INC's shareholders in Q2 2023. To view ADVERUM BIOTECHNOLOGIES INC's shareholder history, click here.